PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Ribomic Inc.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (11)

Ribomic Inc. made a loss over the last year. Ribomic Inc. owes ¥0.05 for every ¥1 it owns. Ribomic Inc. made a loss in each of the last two years.

Compared with Healthcare companies in Japan · latest annual results Mar 2026.

P/E ratio

Loss

Ribomic Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

1.32

The share price is 1.32 times Ribomic Inc.'s book value per share, lower than 61% of Healthcare companies in Japan.

Market cap

¥3.6 B

The total market value of all of Ribomic Inc.'s shares at today's price (share price × number of shares), smaller than 86% of Healthcare companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥2.7 B

What Ribomic Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥48.51

Net worth divided by the number of shares. The share price of ¥64.00 is 1.3 times this, which is the P/B above.

Return on equity (ROE)

-42.8%

Ribomic Inc. lost 42.8% of its shareholders' money over the last year, lower than 86% of Healthcare companies in Japan.

Owes vs Owns

0.05×

Ribomic Inc. owes ¥0.05 for every ¥1 it owns (low), lower than 97% of Healthcare companies in Japan.

Dividend yield

None

Ribomic Inc. does not currently pay a dividend.

Revenue growth

+42%

Revenue rose 42% in the year to Mar 2026, and shrank 64% a year on average over 3 years.

Profit growth

Loss

Ribomic Inc. made a loss in each of the last two years.

Profit margin

-38178.7%

Ribomic Inc. lost ¥38179 for every ¥100 of revenue.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Ribomic Inc.: ¥3.6 B ÷ ¥2.7 B (30 Jun 2026) = 1.3.

What is Ribomic Inc.'s return on equity?

Ribomic Inc. lost 42.8% of its shareholders' money over the last year, lower than 86% of Healthcare companies in Japan.

How much does Ribomic Inc. owe compared with what it owns?

Ribomic Inc. owes ¥0.05 for every ¥1 it owns (low), lower than 97% of Healthcare companies in Japan.

Does Ribomic Inc. pay a dividend?

No. Ribomic Inc. does not currently pay a dividend.

Is Ribomic Inc.'s revenue growing?

Revenue rose 42% in the year to Mar 2026, and shrank 64% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.